Patent details

Herbas

VPB

Print

EN | LT

LT - NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839

EN - NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 31/517
		C07D 239/94
		A61P 35/00

European patent
(11)	Number of the document	1480650
(13)	Kind of document	T
(96)	European patent application number	03708319.3
	Date of filing the European patent application	2003-02-24
(97)	Date of publication of the European application	2004-12-01
(45)	Date of publication and mention of the grant of the patent	2010-04-28
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/GB2003/000794
	Date	2003-02-24

PCT application publication
(87)	Number	WO 2003/072108
	Date	2003-09-04

Priority applications
(30)	Number	Date	Country code
	0204392	2002-02-26	GB
	0212462	2002-05-30	GB

Inventors
(72)	GILDAY, John, Peter, AstraZeneca Pharmaceuticals, GB GRAHAM, Anthony, Stephen, GB YMEN, Bo, Ingvar, SE BOHLIN, Martin, SE

Grantee
(73)	AstraZeneca AB, 151 85 Södertälje, SE

Title
(54)	NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839
	NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839